Avidity Biosciences RNA 深 沪
已收盘 01-30 16:00:00 美东时间
72.57
0.000
0.00%
华盛通- 最 高72.655
- 今 开72.57
- 成交量 126.62万股
- 最 低 72.435
- 昨 收 72.57
- 总市值 109.58亿
- 52周最高 72.74
- 市盈率 静 --
- 换手率 0.84%
- 52周最低 21.51
- 委 比 57.15%
- 总股本 1.51亿
- 历史最高 72.74
- 量 比 1.01
- 振 幅 0.30%
- 历史最低 4.825
- 每 手 1
- 风险率 16.95%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Avidity Biosciences Chief Medical Officer Steven George Hughes Reports Disposal of Common Shares
Avidity Biosciences Chief Medical Officer Steven George Hughes Reports Disposal of Common Shares Steven George Hughes, Chief Medical Officer of Avidity Biosciences Inc., has reported a disposal of common shares of the company. The full filing can be accessed through the link below. Disclaimer: This
01-24 06:34
Avidity Biosciences Chief Scientific Officer Michael Flanagan Reports Disposal of Common Shares
Avidity Biosciences Chief Scientific Officer Michael Flanagan Reports Disposal of Common Shares W. Michael Flanagan, Chief Scientific Officer of Avidity Biosciences Inc., has reported a disposal of common shares of the company. The full filing can be accessed through the link below. Disclaimer: This
01-24 06:34
Avidity Biosciences CEO Sarah Boyce Reports Disposal of Common Shares
Avidity Biosciences CEO Sarah Boyce Reports Disposal of Common Shares Sarah Boyce, President and CEO of Avidity Biosciences Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below. Disclaimer: This news brief was created by Public Technologie
01-24 06:34
Avidity Biosciences CFO Michael F. MacLean Reports Disposal of Common Shares
Avidity Biosciences CFO Michael F. MacLean Reports Disposal of Common Shares Michael F. MacLean, Chief Financial Officer of Avidity Biosciences Inc., has reported a disposal of common shares of the company. The full filing can be accessed through the link below. Disclaimer: This news brief was creat
01-24 06:34
Avidity Biosciences Chief Human Resources Officer Teresa McCarthy Reports Disposal of Common Shares
Avidity Biosciences Chief Human Resources Officer Teresa McCarthy Reports Disposal of Common Shares Teresa McCarthy, Chief Human Resources Officer of Avidity Biosciences Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below. Disclaimer: Thi
01-24 06:34
Dyne upgraded at Oppenheimer on upcoming trial readout from Avidity
Oppenheimer upgraded Dyne Therapeutics (DYN) on Wednesday, citing a positive read-through from data that Novartis’ (NVS) buyout target Avidity Biosciences (RNA) is set to release this year from a late...
2025-12-11 02:43
诺华宣布收购Avidity Biosciences
诺华近日宣布达成一项协议，将收购Avidity Biosciences, Inc.，这是一家位于圣地亚哥的生物制药公司、专注于开发一种能将RNA递送至肌肉的新型...
2025-11-25 17:44
Avidity Biosciences Announces MAP For Investigational Therapy Delpacibart Zotadirsen For Eligible People With Duchenne Muscular Dystrophy Mutations Amenable To Exon 44 Skipping In US
Avidity Biosciences, Inc. (NASDAQ:RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCs™), today announced its Managed Access
2025-11-19 22:15
Avidity Biosciences Announces U.S. Managed Access Program (MAP) for Investigational Therapy del-zota in DMD44
SAN DIEGO, Nov. 19, 2025 /PRNewswire/ -- Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonuc...
2025-11-19 22:13
Momentum movers: 10 stocks surging over 40% over the last month
Despite lingering uncertainty in the broader market following recent selloffs, investor enthusiasm has not been entirely dampened. In fact, several large-cap stocks have surged sharply, with some clim...
2025-11-13 02:12
